Pharmaceutical Technology

JUNE 21, 2023

With this pipeline, Empress hopes to address unmet clinical needs in immune and inflammatory conditions, and metabolic, neurologic, oncologic, and pain disorders. Analysts forecast the biologics market to be worth $120 billion more than small molecules by 2027. Murray KcKinnon, PhD He joined Empress as chief scientific officer.

Compounding 52

Compounding Communication Immunization Immunity 52

Pharmacy Times

JUNE 11, 2025

Completion Date (Estimated): June 2027 “For people living with advanced ROS1+ lung cancer, who tend to be diagnosed at a younger age, having another treatment option can make a real difference for them and their loved ones,” Janet Freeman-Daily, cofounder and president of The ROS1ders, said in a news release.

Pharmacy Technician 26

Pharmacy Technician Biosimilars Compounding Pharmacies Pharmacy Management 26

Pharmaceutical Technology

APRIL 24, 2023

. “Biologics products may contain proteins that control the action of other proteins and cellular processes, genes that control production of vital proteins, modified human hormones, or cells that produce substances that suppress or activate components of the immune system.

Vaccines 52

Vaccines Compounding Communication Immunization 52

European Pharmaceutical Review

MARCH 4, 2024

Indeed, in 2022, biologics constituted 40 percent of all US Food and Drug Administration (FDA) approved drugs, projecting a compound annual growth rate (CAGR) of 9.5 percent through 2027. The market for biologics The growing interest in biologics resonates with their impressive expansion on the global market.

Vaccines 98

Vaccines Immunization Immunity Compounding 98